Seem DL, Lee I, Umscheid CA, Kuehnert MJ. PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public Health Rep. 2013;128(4):247-343.
Seem DL, Lee I, Umscheid CA, Kuehnert MJ. Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation. Am J Transplant. 2013;13(8):1953-1962.
Selph S, Chou R. Impact of contacting study authors on systematic review conclusions: diagnostic tests for hepatic fibrosis. 2014;Rockville, MD: Agency for Healthcare Research and Quality.
Selvapatt N, Ward T, Bailey H, et al. Is antenatal screening for hepatitis C virus cost-effective? A decade's experience at a London centre. Bennett H, Thorne C, See L-M, et al., eds. J Hepatology. 2015;63(4):797-804.
Department of Health and Human Services (DHHS). Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. 2017. Available at: Accessed Accessed June 13, 2019.
Shaw K, Gennat H, O'Rourke P, DelMar C. Exercise for overweight or obesity. Cochrane Database Syst Rev. 2006;18(4):CD003817.
Shebl FM, El-Kamary SS, Saleh D'aA, et al. Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages. Abdel-Hamid M, Mikhail N, Allam A, et al., eds. J Med Virol. 2009;81(6):1024-1031.
Shelton BA, Sawinski D, Mehta S, Reed RD, MacLennan PA, Locke JE. Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney. Transpl Infect Dis. 2018;20:e12829.
Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann Intern Med. 2003;139(6):493-498.
Simmons B, Saleem J, Hill A, Riley RD, Cooke GS. Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis. Clin Infect Dis. 2016;62(6):683-694. doi:10.1093/cid/civ948.
Singal AG, Volk ML, Jensen D, Di Bisceglie AM, Schoenfeld PS. A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus. Clin Gastroenterol Hepatol. 2010;8(3):280-288, 288e1.
Sise ME, Bloom AK, Wisocky J, et al. Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Lin MV, Gustafson JL, Lundquist AL, et al., eds. Hepatology. 2016;63(2):408-417.
Smith BD, Morgan RL, Beckett GA, et al, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. Falck-Ytter Y, Holtzman D, Teo CG, et al., eds. MMWR Recomm Rep. 2012;61(RR-4):1-32.
Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Ward JW. Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention. Ann Intern Med. 2012;157(11):817-822.
Smith BD, Jewett A, Burt RD, Zibbell JE, Yartel AK, DiNenno E. "To share or not to share?" Serosorting by hepatitis C status in the sharing of drug injection equipment among NHBS-IDU2 participants. J Infect Dis. 2013;208(12):1934-1942.
Smolders EJ, Colbers EP, de Kanter CT, et al. Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistat. Velthoven-Graafland K, Drenth JPH, Burger DM, eds. J Antimicrob Chemother. 2017;72(2):486-489.
Söderholm J, Millbourn C, Büsch K, et al. Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis. J Hepatol. 2018;68(5):904-911. doi:10.1016/j.jhep.2017.12.003.
Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;(357):j1550.
Soriano V, Benítez-Gutiérrez L, Arias A, et al. Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C. Expert Opin Drug Metab Toxicol. 2017;13(9):1015-1022.
Soriano V, Barreiro P, deMendoza C. Hypoglycemia in a diabetic patient during hepatitis C therapy. Hepatology. 2016;(63):2065-2066.